関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | 5-Bromo-2-methoxybenzonitrile | HCID 4418560 | — |
| 反応物 | (R)-2-(tert-butyldimethylsilyloxy)propan-1-amine | HCID 59302513 | — |
| 試薬 | Cesium carbonate | HCID 10796 | — |
| 触媒 | Palladium (II) acetate | HCID 4144353 | — |
| 触媒 | 2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl | HCID 11155794 | — |
| 溶媒 | Toluene | HCID 1140 | — |
| 生成物 | (R)-5-(2-(tert-butyldimethylsilyloxy)propylamino)-2-methoxybenzonitrile | HCID 58464488 | 47.64% |
反応手順
PdOAc2 (0.529 g, 2.36 mmol) and dicyclohexyl(2',4',6'-triisopropylbiphenyl-2-yl)phosphine (1.124 g, 2.36 mmol) were added in one portion to a degassed solution of 5-bromo-2-methoxybenzonitrile (5 g, 23.58 mmol), (R)-2-(tert- butyldimethylsilyloxy)propan-1-amine (5.36 g, 28.30 mmol) and cesium carbonate (11.52 g, 35.37 mmol) in toluene (100 mL) at 20°C under nitrogen. The resulting suspension was stirred at 120 °C for 50 hours. The reaction mixture was diluted with EtOAc (150 mL) and water (150 mL) and the biphasic mixture was filtered through celite. The organic layer was separated and washed sequentially with water (150 mL) and saturated brine (150 mL). The organic layer was evaporated to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 20% EtOAc in isohexane. Pure fractions were evaporated to dryness to afford (R)-5-(2-(tert- butyldimethylsilyloxy)propylamino)-2-methoxybenzonitrile (3.60 g, 47.6 %) as a pale yellow oil.
情報源と証拠
| 出典データセット | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-3a15989581314d86a106f9d713384402 |
|---|
| 出典メモ | 750 AstraZeneca ELN dataset |
|---|